Gonadorelin is synthetic native Gonadotropin-Releasing Hormone (GnRH), a 10-amino acid hypothalamic decapeptide used to investigate pulsatile LH and FSH gonadotroph signaling via GnRHR.
Scientific Profile & Research Key Points: Gonadorelin
Gonadorelin is synthetic native Gonadotropin-Releasing Hormone (GnRH), a 10-amino acid hypothalamic decapeptide used to investigate pulsatile LH and FSH gonadotroph signaling via GnRHR.
Active Batch Release Specifications (Lot SL-2026-129)
Analytical release verification for current Gonadorelin (10 mg) inventory
| Batch Lot # | Release Date | Analytical Method | Purity Spec | Endotoxin (LAL) | Moisture |
|---|---|---|---|---|---|
| SL-2026-129 | 2026-10-28 | RP-HPLC (C18, 214nm) + ESI-MS | ≥99.0% (Single Peak) | <0.5 EU/mg | <2.8% (Karl Fischer) |
Laboratory Solubilization & Storage Protocol
Recommended Solvent / Handling
Sterile 0.9% Bacteriostatic Water or sterile 0.9% saline
Temperature & Stability
Store lyophilized at -20°C away from light; refrigerate solution at 2°C–8°C for up to 21 days.
Gonadorelin — Technical Questions & Answers
What is the molar concentration when reconstituting Gonadorelin (10 mg) in 2.0 mL?
Reconstituting the full 10 mg vial of Gonadorelin (MW 1182.29 g/mol) in 2.0 mL of diluent produces a 5.00 mg/mL stock solution — equivalent to approximately 4.23 mM (4,229 µM) gross molarity before Net Peptide Content (NPC) adjustment.
How does Gonadorelin's counterion stoichiometry affect assay mass calculations?
Gonadorelin (CAS 33515-09-2, formula C55H75N17O13) is supplied as Acetate lyophilized salt. Because counterions and residual bound water contribute to gross lyophilized weight, quantitative receptor-binding assays should apply batch Net Peptide Content (NPC) or active-ion correction rather than gross cake weight alone.
Which analytical methods verify Gonadorelin Lot SL-2026-129 and what pathway does it target?
Lot SL-2026-129 undergoes RP-HPLC (C18, 214nm) + ESI-MS confirming ≥99.0% (Single Peak) and identity against 1182.29 g/mol. In preclinical literature, Gonadorelin targets Pituitary Gonadotropin-Releasing Hormone Receptor (GnRHR) (Matsuo H. et al., Biochem Biophys Res Commun (1971) — Structure of hypothalamic LH/FSH-releasing decapeptide (PMID: 4936338)).
Related Scientific Monographs
Peer-reviewed mechanism summaries and analytical protocols
Gonadorelin, HCG, HMG and Kisspeptin: Mapping the Hypothalamic-Pituitary-Gonadal Axis
A comparative map of the HPG axis: GnRH receptor agonism (Gonadorelin), LH receptor mimetics (HCG), combined FSH/LH activity (HMG), and upstream GPR54 activation (Kisspeptin-10).
How to Read a Peptide Certificate of Analysis (COA): Step-by-Step Breakdown
A practical guide for researchers. How to analyze HPLC chromatograms, verify retention time, interpret mass spec m/z peaks, evaluate counterion salt ratios, and spot fraudulent documents.
How to Reconstitute Research Peptides: Complete Laboratory Protocol and Best Practices
Standard Operating Procedure (SOP) for peptide reconstitution. Diluent selection (BAC water vs acetic acid), meniscus calculations, avoiding foaming, and cold storage parameters.